DejaVue HealthGrid

DejaVue HealthGrid DejaVue HealthGrid DejaVue HealthGrid

DejaVue HealthGrid

DejaVue HealthGrid DejaVue HealthGrid DejaVue HealthGrid

Bringing Prenatal Ultrasound From Hospitals to the Hands of Women. Anywhere

Bringing Prenatal Ultrasound From Hospitals to the Hands of Women. AnywhereBringing Prenatal Ultrasound From Hospitals to the Hands of Women. AnywhereBringing Prenatal Ultrasound From Hospitals to the Hands of Women. Anywhere

The Problem

✅ Sonographer shortages

✅ Scheduling constraints

✅ Sonographer shortages

✅Clinic bottlenecks

✅ Scheduling constraints

✅ Sonographer shortages

✅ Scheduling constraints

✅ Scheduling constraints

✅ Rural commuting barriers

✅ Rural commuting barriers

✅ Stigma in hospital settings for women with SUD

✅ Rural commuting barriers

✅ Stigma in hospital settings for women with SUD

✅ Stigma in hospital settings for women with SUD

✅ Stigma in hospital settings for women with SUD

Our Solution

🧠 AI-Assisted Image Analysis

🧠 AI-Assisted Image Analysis

🧠 AI-Assisted Image Analysis

   Real-time guidance, image quality scoring, gestational age estimation, and anomaly flagging. 

🛠 Portable Ultrasound Device

🧠 AI-Assisted Image Analysis

🧠 AI-Assisted Image Analysis

  Compact handheld scanner designed for point-of-care and assisted self-scanning. 

🌐Remote Physician Oversight

🧠 AI-Assisted Image Analysis

🌐Remote Physician Oversight

 Secure cloud dashboard enabling OB/GYN review and coordination of care. 

🔥 WE STARTED BUILDING.

One platform. Any ultrasound. DejaVue HealthGrid is redefining how imaging meets care.

  We are actively seeking partners to expand access and redefine prenatal care together. 

What is DejaVue SUD+?

 DejaVue SUD+ bridges that gap with a safe, stigma-free solution that meets women where they are—at home, in care, or in recovery. 

DejaVue NeuroMat™

AI-Assisted Neuromuscular Diagnostic Platform for Pregnancy and Postpartum Care

Product Aims

  1. Prototype Finalization: Develop and verify  the clinical-grade NeuroMat™ system.
  2. Preclinical Safety Testing: Perform  biocompatibility, signal fidelity, and electrical safety assessments.
  3. Feasibility Trial: Conduct a 30-patient  IRB-approved clinical study to evaluate neuromuscular pattern detection.
  4. AI Model Validation: Refine diagnostic  algorithms using anonymized clinical data.
  5. Cloud Integration: Deploy clinician dashboard with HIPAA-compliant backend infrastructure.

Provisional Patent # 63/840479

 


Market & Opportunity

 

$7B+ Global Prenatal Market | 31,000+ Clinics in U.S. | 2,300+ Clinics in California

 

Capitalization Table

Pre-Money Valuation: $5M SAFE Note Terms: $250K for a projected 5% equity stake, with a 30% discount at the next priced round.

Projected ROI at Exit ($50M – $100M): 10–20x ROI potential driven by:

  • SaaS scalability
  • Neurology and maternal health market penetration
  • Strategic acquisition interest

 

Stay in the Loop

 Reach out to learn more about DejaVue’s AI ultrasound system, partnership opportunities, clinical pilots, or support for global maternal health. 

How It Works

Join the Beta for DejaVue Portable Prenatal System

Your support and contributions will enable us to meet our goals and fund our mission.

Pitch Deck Available Upon Request

Contact DejaVue | Partner, Pilot, or Support Our Mission

Reserve Your Spot – Help Us Bring Prenatal Innovation to Life

Copyright © 2026 DejaVueAI - All Rights Reserved.

Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept